Hemab Therapeutics Holdings, Inc.
44.50USD
-0.0700 (-0.16%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| Operating Income | -26 | -24 | -16 | -17 |
| Net Income | -24 | -23 | -12 | -15 |
| EPS (Diluted) | $-0.80 | $-23.98 | $-12.91 | $-16.18 |
Source: SEC filings (EDGAR)